Literature DB >> 3499262

Enzyme-linked immunosorbent assay (ELISA) for human epidermal growth factor (hEGF).

Y Abe1, T Sagawa, K Sakai, S Kimura.   

Abstract

An enzyme-linked immunosorbent assay for human epidermal growth factor (hEGF) by the sandwich method with the use of orthophenylene diamine (OPDA) for the substrate of the enzyme reaction was developed. This assay showed high sensitivity, and there was no problem with the recovery rates even without any pretreatment of samples. The changes of hEGF levels in plasma and serum depend on the condition of blood storage from sampling until separation of the cell content. The levels of hEGF markedly increased with time in serum, especially when stored at room temperature but less so in plasma. Changes of hEGF levels in plasma were negligible for up to 3 h if the blood was stored at 4 degrees C until separation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499262     DOI: 10.1016/0009-8981(87)90270-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Urine human epidermal growth factor (hEGF) levels following surgery.

Authors:  Y Abe; M Miyake; T Sagawa; S Kimura
Journal:  Jpn J Surg       Date:  1988-11

2.  Development and validation of two solid-phase enzyme immunoassays (ELISA) for quantitation of human epidermal growth factors (hEGFs).

Authors:  N Sizemore; R C Dudeck; C M Barksdale; G D Nordblom; W T Mueller; P McConnell; D S Wright; A Guglietta; B S Kuo
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

3.  Effects of epidermal growth factor and its signal transduction inhibitors on apoptosis in human colorectal cancer cells.

Authors:  Jane C J Chao; Wen Li Peng; Sheng-Hsuan Chen
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

4.  Decreased urinary epidermal growth factor levels in diabetic patients.

Authors:  Y Abe; M Miyake; A Horiuchi; S Kimura
Journal:  Jpn J Surg       Date:  1991-07

5.  The effects of intracolonic EGF on mucosal growth and experimental carcinogenesis.

Authors:  J R Reeves; R C Richards; T Cooke
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.